Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667
- Status
- TERMINATED
- Phase
- PHASE2
Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
- Status
- TERMINATED
- Phase
- PHASE4
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE3
Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
- Status
- UNKNOWN
- Phase
- PHASE4
Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
- Status
- COMPLETED
- Phase
- NA
BENEFIT Extension Study
- Status
- COMPLETED
- Phase
- N/A
Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ZK283197 for Treatment of Vasomotor Symptoms
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock
- Status
- COMPLETED
- Phase
- PHASE3
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2